Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
betulinic acid nanoformulation (APH-0202)
i
Other names:
APH-0202
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Aphios
Drug class:
Maturation inhibitor
‹
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
MLL rearrangement
Acute Lymphocytic Leukemia
MLL rearrangement
Acute Lymphocytic Leukemia
doxorubicin hydrochloride + APH-0202
Sensitive: D – Preclinical
doxorubicin hydrochloride + APH-0202
Sensitive
:
D
doxorubicin hydrochloride + APH-0202
Sensitive: D – Preclinical
doxorubicin hydrochloride + APH-0202
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.